SURG Surgepays Inc

  1. Stocks
  2. Technology
  3. NASDAQ: SURG

Price (delayed)

$0.2128

Market cap

$5.35M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.94

Enterprise value

$18.44M

?
Relative Growth: Rel. Growth: 44
Relative Strength: Rel. Strength: 0
Relative Valuation: Rel. Valuation: 42
Relative Profitability: Rel. Profitability: 9

Synergetics USA, Inc. (Synergetics USA) is a supplier of precision surgical devices. The Company's primary focus is on the disciplines of ophthalmology and neurosurgery. The Company's product lines focus upon ...

Highlights
The company's revenue has surged by 56% YoY and by 9% QoQ
The gross margin has surged by 61% year-on-year but it has declined by 32% since the previous quarter
SURG's gross profit is down by 45% since the previous quarter but it is up by 40% year-on-year
The quick ratio has dropped by 82% year-on-year and by 24% since the previous quarter
Surgepays's equity has shrunk by 55% QoQ
Sector: Technology
Industry: Software - Application
Website: http://www.surgepays.com
Peers: CRM NOW ZM DOCU

Key stats

What are the main financial stats of SURG

SURG stock price

How has the Surgepays stock price performed over time
Intraday
-2.39%
1 week
-12.07%
1 month
-62.86%
1 year
-92.12%
YTD
-87.26%
QTD
-41.05%

Financial performance

How have Surgepays's revenue and profit performed over time
Revenue
$62.37M
Gross profit
-$15.34M
Operating income
-$37.76M
Net income
-$40.48M
Gross margin
-24.6%
Net margin
-64.9%
The gross margin has surged by 61% year-on-year but it has declined by 32% since the previous quarter
The company's revenue has surged by 56% YoY and by 9% QoQ
Surgepays's operating margin has surged by 53% YoY
Surgepays's net margin has surged by 52% YoY but it has decreased by 2.5% QoQ

Price vs fundamentals

How does SURG's price correlate with its fundamentals

Growth

What is Surgepays's growth rate over time

Valuation

What is Surgepays stock price valuation
SURG P/E details
P/E
N/A
P/B
N/A
P/S
0.08
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.3
Surgepays's EPS has increased by 30% YoY but it has decreased by 8% from the previous quarter
Surgepays's equity has shrunk by 55% QoQ
SURG's P/S is 91% below its last 4 quarters average of 0.9 and 89% below its 5-year quarterly average of 0.7
The company's revenue has surged by 56% YoY and by 9% QoQ

Efficiency

How efficient is Surgepays business performance
Surgepays's ROA has plunged by 114% YoY and by 27% from the previous quarter
Surgepays's ROS has soared by 53% YoY

Dividends

What is SURG's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SURG.

Financial health

How did Surgepays financials performed over time
Surgepays's total assets is 72% lower than its total liabilities
The current ratio has plunged by 84% YoY and by 29% from the previous quarter
The quick ratio has dropped by 82% year-on-year and by 24% since the previous quarter
Surgepays's debt is 165% higher than its equity
Surgepays's equity has shrunk by 55% QoQ
Surgepays's debt to equity has increased by 26% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.